Tag Archives: acute lymphoblastic leukemia (ALL)

09Feb/18

Carl June: The World’s First CAR-T Therapy Released the Latest Data

February 9, 2018Chimeric Antigen Receptor Research, Newsacute lymphoblastic leukemia (ALL), CAR-T, CAR-T therapy, Chimeric antigen receptor (CAR)biocart

On February 1, NEJM, the top medical journal, published the results of a pivotal multi-center critical phase 2 trial in support of the “first CAR-T therapy Tisagenlecleucel listed”. The overall survival of patientsRead More…

10Jan/18

What Is CD19 Antigen?

January 10, 2018Chimeric Antigen Receptor Researchacute lymphoblastic leukemia (ALL), CAR-T, CD19 antigen, chimeric antigen receptors (CARs)biocart

As the data from clinicaltrials.gov shows, CD19 antigen is the most frequently used biomarker in CAR-T cell therapy clinical trials for hematological malignancy such as leukemia and lymphoma. According to our statistics report, overRead More…

Chimeric Antigen Receptor Research
TCR Research
Oncolytic Virus Therapy Research
News